(Q35889591)

10 August 2017

1 reference

title

Antitoxins: novel strategies to target agents of bioterrorism (English)

1 reference

10 August 2017

0 references

G Jonah A Rainey

1

1 reference

10 August 2017

John A T Young

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Nature Reviews Microbiology

10 August 2017

published in

1 reference

10 August 2017

volume

2

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

721-726

1 reference

Identification of the major steps in botulinum toxin action

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Therapeutic challenges posed by bacterial bioterrorism threats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Anthrax lethal toxin induces human endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Identification of the cellular receptor for anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Binding of Anthrax Toxin to Its Receptor Is Similar to α Integrin-Ligand Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Human antibodies from immunized donors are protective against anthrax toxin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Designing a polyvalent inhibitor of anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Screening inhibitors of anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Development of Potent Inhibitors of Botulinum Neurotoxin Type B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

In vitro selection of RNA molecules that inhibit the activity of ricin A-chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Ricin A-chain inhibitors resembling the oxacarbenium ion transition state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Identification of small molecule inhibitors of anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Potent inhibitors of anthrax lethal factor from green tea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Structure-based identification of a ricin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Ricin. Mechanisms of cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1' binding subsite

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO977

31 March 2020

Identifiers

DOI

10.1038/NRMICRO977

1 reference

release_qopztqykrjhilbzmbrxmlvlpum

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qopztqykrjhilbzmbrxmlvlpum

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference